Ayorinde is a Scientist at the Department of Clinical Pharmacology at the Mahidol Oxford Tropical Medicine Research Unit (MORU) in Bangkok. With a background in Biochemistry and Pharmaceutical Chemistry, Ayorinde’s research interests lie in pharmacokinetics and the use of pharmacometrics tools for improved decision making in preclinical and clinical settings.
Ayorinde joined MORU in 2021. Currently, he works in malaria and chagas disease, developing mathematical models that will expand the understanding of infection-dynamics and optimise drug-use in these diseases.
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
Assmus F. et al, (2022), Microorganisms, 10, 1639 - 1639
Evaluation of the impact of CYP1A2 induction by charbroiled meal on metabolic phenotype (vol 27, pg 96, 2019)
George JA. et al, (2021), CLINICAL NUTRITION ESPEN, 42, 416 - 416
A compartmental approach to isosteviol's disposition in Sprague-Dawley rats.
Adehin A. et al, (2020), Naunyn-Schmiedeberg's archives of pharmacology, 393, 1003 - 1011
Influence of MAMA decoction, an Herbal Antimalarial, on the Pharmacokinetics of Amodiaquine in Mice.
Adepiti AO. et al, (2020), European journal of drug metabolism and pharmacokinetics, 45, 81 - 88
Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy.
Adehin A. et al, (2020), Breast cancer (Dove Medical Press), 12, 123 - 130